Use of selective serotonin reuptake inhibitors by pediatricians: Comparing attitudes of primary care pediatricians and child and adolescent psychiatrists

Clinical Pediatrics

Volumn 47, Issue 2, 2008, Pages 148-154

  Heneghan, Amy ^a   Garner, Andrew S ^a,b,c   Storfer Isser, Amy ^a,b   Kortepeter, Karl ^a   Stein, Ruth E K ^d   McCue Horwitz, Sarah ^e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pediatricians; Psychiatry; SSRIs

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PEDIATRICIAN; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; PSYCHIATRIST;

ADOLESCENT PSYCHIATRY; ADULT; ATTITUDE OF HEALTH PERSONNEL; CHILD PSYCHIATRY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; SEROTONIN UPTAKE INHIBITORS;

EID: 38849169902     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922807306169     Document Type: Article

References (31)

1. Son S., Kirchner J. Depression in children and adolescents. Am Fam Physician. 2000 ; 62: 2297-2308, 2311-2312.
2. Shaffer D., Fisher P., Lucas C., Dulcan M., Schwab-Stone M. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry. 2000 ; 39: 28-38.
3. Klerman G., Weissman M. Increasing rates of depression. JAMA. 1989 ; 261: 2229-2235.
4. Jellinek M., Snyder J. Depression and suicide in children and adolescents. Pediatric Rev. 1998 ; 19: 255-264.
5. Birmaher B., Ryan N., Williamson D., et al. Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry. 1996 ; 35: 1427-1439.
6. Safer D., Zito J., DosReis S. Concomitant psychotropic medication for youths Am J Psychiatry. 2003 ; 160: 438-449.
7. Ruston J., Clark S., Freed G. Primary care role in the management of childhood depression: a comparison of pediatricians and family physicians. Pediatrics. 2000 ; 105: 957-962.
8. Olfson M., Marcus S., Weissman M., Jensen P. National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry. 2002 ; 41: 514-521.
9. Emslie G., Rush A., Weinberg W., et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997 ; 54: 1031-1037.
10. Emslie G., Heiligenstein J., Wagner K., et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2002 ; 41: 1205-1215.
11. DeVane C., Sallee F. Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience. J Clin Psychiatry. 1996 ; 57: 55-66.
12. March J., Silva S., Petrycki S., et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004 ; 292: 807-820.
13. Leslie L., Newman T., Chesney P., Perrin J. The Food and Drug Administration's deliberations on antidepressant use in pediatric patients. Pediatrics. 2005 ; 116: 195-204.
14. FDA Public Health Advisory. Suicidality in Children and Adolescents Being Treated with Antidepressant Medications. October 15, 2004. Available at: http://www.fda.gov/cder/drug/antidepressants/SSRIPHA200410.htm. Accessed March 8, 2007.
15. Kaizar E., Greenhouse J., Seltman H., Kelleher K. Do antidepressants cause suicidality in children? A Bayesian meta-analysis. Clin Trials. 2006 ; 3: 73-98.
16. Safer D. Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders? Pediatrics. 2006 ; 118: 1248-1251.
17. Wagner K., Ambrosini P., Rynn M., et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA. 2003 ; 290: 1033-1041.
18. Hammad T. Results of the Analysis of Suicidality in Pediatric Trials of Newer Antidepressants. 2004. Available at: http://www.fda.gov/ohrms/dockets/ac/ 04/slides/2004-4065S1.htm. Accessed May 7, 2007.
19. Rigoni GC Drug Utilization for Selected Antidepressants Among children and Adolescents in the US. 2004. Available at: http://www.fda.gov/ohrms/dockets/ ac/04/slides/4006S1_04_Rigoni_files/frame.htm. Accessed May 7, 2007.
20. Kelleher K., McInerny T., Gardner W., Childs G., Wasserman R. Increasing identification of psychosocial problems: 1979-1996. Pediatrics. 2000 ; 105: 1313-1321.
21. Costello E., Pantino T. The new morbidity: who should treat it ? J Dev Behav Pediatr. 1987 ; 8: 288-291.
22. Bernal P. Hidden morbidity in pediatric primary care. Pediatr Ann. 2003 ; 32: 413-418.
23. Horwitz S., Kelleher K., Stein R., et al. Barriers to the identification and management of psychosocial issues in children and maternal depression. Pediatrics. 2007 ; 119: 208-218.
24. Willaims J., Klinepeter K., Palmes G., Pulley A., Foy J. Diagnosis and treatment of behavioral health disorders in pediatric practice. Pediatrics. 2004 ; 114: 601-606.
25. Kelleher K., Campo J., Gardner W. Management of pediatric mental disorders in primary care: where are we now and where are we going ? Curr Opin Pediatr. 2006 ; 18: 649-653.
26. Cummings S., Savitz L., Konrad T. Reported response rates to mailed physician questionnaires. Health Serv Res. 2001 ; 35: 1347-1355.
27. Asch D., Jedrziewski M., Christakis N. Response rates to mail surveys published in medical journals. J Clin Epidemiol. 1997 ; 50: 1129-1136.
28. American Academy of Pediatrics. SoA-DHDaCoQaI. Clinical practice guideline: treatment of the school-age child with attention-deficit/ hyperactivity disorder. Pediatrics. 2001 ; 108: 1033-1044.
29. Wright RJ, Wright RO, Isaac NE Response to battered mothers in the pediatric emergency department: a call for an interdisciplinary approach to family violence. Pediatrics. 1997 ; 99: 186-192.
30. Wegner L. Pediatricians and antidepressant medications: black box or black hole ? Pediatrics. 2005 ; 116: 233-235.
31. Greenhouse J., Kelleher K. Thinking outside the (black) box: antidepressants, suicidality, and research synthesis. Pediatrics. 2005 ; 116: 231-233.